{"podcast":{"title":"Decera Clinical Education Oncology Podcast","slug":"decera-clinical-education-oncology-podcast-1302999","podcast_index_feed_id":1302999,"rss_url":"https://feeds.simplecast.com/GlfUTtJq","website_url":"https://oncologypodcast.simplecast.com","image_url":"https://image.simplecastcdn.com/images/ec61b327-3a4f-4bed-a4d2-7c7d2df62891/2d9bf1a9-d5c4-4079-9b3e-a531bfcf7774/3000x3000/decera-onc-podcast-show-icon.jpg?aid=rss_feed","author":"Decera Clinical Education","episode_count":253,"summary":"Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.","last_synced_at":"2026-07-15T02:18:52.844818+00:00","page_url":"https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999"},"episode":{"title":"Oncologists “On Call”: Our Practical Experiences to Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma","slug":"oncologists-on-call-our-practical-experiences-to-optimizing-bispecific-antibody-therapy-in-relapsed-refractory-multiple-myeloma","published_at":"2026-05-07T13:14:37+00:00","page_url":"https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999/oncologists-on-call-our-practical-experiences-to-optimizing-bispecific-antibody-therapy-in-relapsed-refractory-multiple-myeloma","show_page_url":"https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999","url":"https://oncologypodcast.simplecast.com/episodes/oncologists-on-call-our-practical-experiences-to-optimizing-bispecific-antibody-therapy-in-relapsed-refractory-multiple-myeloma-g4ris29j","audio_url":"https://afp-928689-injected.calisto.simplecastaudio.com/1d8e143b-904e-45be-b6c5-8fba793d9d74/episodes/e008a55d-649a-4523-bbb3-d6a1070944e5/audio/128/default.mp3?aid=rss_feed&awCollectionId=1d8e143b-904e-45be-b6c5-8fba793d9d74&awEpisodeId=e008a55d-649a-4523-bbb3-d6a1070944e5&feed=GlfUTtJq","summary":"Enhance your knowledge and optimize treatment for patients with R/R MM by learning from subject matter experts Muhamed Baljevic, MD, FACP, and Johnathan Ticku, MD, in this podcast. Listen as they discuss various strategies to optimize the use of bispecific antibodies in their practices through patient monitoring, dosing in outpatient settings, and utilizing tocilizumab and IVIG among other management strategies.","meta_description":"Enhance your knowledge and optimize treatment for patients with R/R MM by learning from subject matter experts Muhamed Baljevic, MD, FACP, and Johnathan T…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1860,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/oncologists-on-call-our-practical-experiences-to-optimizing-bispecific-antibody-therapy-in-relapsed-refractory-multiple-myeloma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999/oncologists-on-call-our-practical-experiences-to-optimizing-bispecific-antibody-therapy-in-relapsed-refractory-multiple-myeloma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}